Literature DB >> 1515270

The influence of age on treatment choice and survival of elderly breast cancer patients in south-eastern Netherlands: a population-based study.

L Bergman1, H M Kluck, F E van Leeuwen, M A Crommelin, G Dekker, A A Hart, J W Coebergh.   

Abstract

The influence of age on treatment choice and survival was studied in 2268 breast cancer patients of 55 years and older reported to the Eindhoven Cancer Registry from 1975 to 1987. Among patients of 75 years and older, stage I and II tumours occurred less often, whereas stage IIIb and undefined tumours occurred more often than among younger patients. Physicians were found to be less likely to treat women of 75 years and older with adjuvant radiotherapy after a mastectomy. Instead, these women received either surgery alone or surgery followed by hormonal therapy. Surgical procedures in the oldest age group were also less extensive. The 10-year relative survival for women over 74 years (32%) was significantly worse than that for younger patients (57%). Multivariate analyses showed that this poor outcome for the oldest age group was largely related to their unfavourable stage distribution: stage-specific survival appeared to be similar in all age groups. Age-related differences in treatment did not have an effect on survival.

Entities:  

Mesh:

Year:  1992        PMID: 1515270     DOI: 10.1016/0959-8049(92)90547-f

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  14 in total

1.  A retrospective study of the impact of age on patterns of care for elderly patients with metastatic breast cancer.

Authors:  Kenji Hashimoto; Kan Yonemori; Chikako Shimizu; Akihiro Hirakawa; Harukaze Yamamoto; Makiko Ono; Taizo Hirata; Tsutomu Kouno; Kenji Tamura; Noriyuki Katsumata; Masashi Ando; Yasuhiro Fujiwara
Journal:  Med Oncol       Date:  2010-03-31       Impact factor: 3.064

Review 2.  Mammographic screening in older women. Is it worthwhile?

Authors:  J A van Dijck; M J Broeders; A L Verbeek
Journal:  Drugs Aging       Date:  1997-02       Impact factor: 3.923

3.  Pathologic and clinical characteristics of elderly patients with breast cancer: a retrospective analysis of a multicenter study (Anatolian Society of Medical Oncology).

Authors:  Ali Inal; Tulay Akman; Sebnem Yaman; Selcuk Cemil Ozturk; Caglayan Geredeli; Mehmet Bilici; Mevlude Inanc; Hakan Harputoglu; Umut Demirci; Ozan Balakan; Havva Yesil Cınkır; Suleyman Alıcı; Dilsen Colak; Ozlem Uysal Sonmez; Gamze Goksel; Gamze Gokoz Dogu; Huseyin Engin; Olcun Umit Unal; Tulay Tamozlu; Suleyman Buyukberber; Cem Melih Boruban; Abdurrahman Isıkdogan
Journal:  Int Surg       Date:  2014 Jan-Feb

Review 4.  Breast cancer in the elderly.

Authors:  M Bellet; C Alonso; B Ojeda
Journal:  Postgrad Med J       Date:  1995-11       Impact factor: 2.401

Review 5.  Managing breast cancer in the older patient.

Authors:  Tracey O'Connor; Arvind Shinde; Caroline Doan; Vani Katheria; Arti Hurria
Journal:  Clin Adv Hematol Oncol       Date:  2013-06

Review 6.  Epidemiology of breast cancer in older women: implications for future healthcare.

Authors:  A J Alberg; S Singh
Journal:  Drugs Aging       Date:  2001       Impact factor: 4.271

7.  Hormone treatment without surgery for patients aged 75 years or older with operable breast cancer.

Authors:  C J Wink; K Woensdregt; G A P Nieuwenhuijzen; M J C van der Sangen; S Hutschemaekers; J A Roukema; V C G Tjan-Heijnen; A C Voogd
Journal:  Ann Surg Oncol       Date:  2011-10-27       Impact factor: 5.344

8.  Position paper by the UKCCCR elderly cancer patients in clinical trials working group.

Authors: 
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

9.  Geriatric oncology: The need for a separate subspecialty.

Authors:  D K Vijaykumar; R Anupama; Tejal Kishor Gorasia; T R Haleema Beegum; P Gangadharan
Journal:  Indian J Med Paediatr Oncol       Date:  2012-04

Review 10.  Early breast cancer in the elderly: assessment and management considerations.

Authors:  Gilles Albrand; Catherine Terret
Journal:  Drugs Aging       Date:  2008       Impact factor: 4.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.